Intellipharmaceutics International Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Toronto, Ontario, Canada
SEC filing record 1 source field available
Fiscal year end
30 November
Intellipharmaceutics International Inc. has filed 473 SEC EDGAR filings since 22 Oct 2009

SEC filing history

Showing 101-125 of 469 matching filings.

Per page
25
Current page
5
6-K File 000-53805

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-227448

PRIMARY DOCUMENT

Filing date
26 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-226239

PRIMARY DOCUMENT

Filing date
26 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-53805

PRIMARY DOCUMENT

Filing date
22 Feb 2019
Reporting date
30 Nov 2018
Next action
Verify source filing
424B3 File 333-227448

PRIMARY DOCUMENT

Filing date
20 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-226239

PRIMARY DOCUMENT

Filing date
20 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-53805

PRIMARY DOCUMENT

Filing date
20 Feb 2019
Reporting date
20 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85064

SC 13G/A filing

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85064

SC 13G/A

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-226239

PRIMARY DOCUMENT

Filing date
04 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-227448

PRIMARY DOCUMENT

Filing date
04 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-53805

PRIMARY DOCUMENT

Filing date
04 Feb 2019
Reporting date
04 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85064

INTELLIPHARMACEUTICS INTERNATIONAL INC.

Filing date
01 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85064

SABBY 13G-A IPCI 1.29.19

Filing date
29 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85064

SABBY 13G IPCI 1.29.19

Filing date
29 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-227448

PRIMARY DOCUMENT

Filing date
28 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-226239

PRIMARY DOCUMENT

Filing date
28 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-53805

PRIMARY DOCUMENT

Filing date
28 Jan 2019
Reporting date
28 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-226239

PRIMARY DOCUMENT

Filing date
07 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-227448

PRIMARY DOCUMENT

Filing date
07 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-53805

PRIMARY DOCUMENT

Filing date
07 Jan 2019
Reporting date
07 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-227448

PRIMARY DOCUMENT

Filing date
06 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-226239

PRIMARY DOCUMENT

Filing date
06 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-53805

PRIMARY DOCUMENT

Filing date
05 Dec 2018
Reporting date
04 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .